The latest announcement is out from Novavax ( (NVAX) ).
Novavax (NVAX) stock is in focus as the company assign its Gaithersburg facility to AstraZeneca (AZN) in a deal worth nearly ...
Novavax, Inc. (Nasdaq: NVAX) today announced that it has further executed against its planned transformation into a lean, ...
Novavax (NVAX) ended the recent trading session at $8.46, demonstrating a -1.51% change from the preceding day's closing price. This change lagged the S&P 500's 0.53% loss on the day. Meanwhile, the ...
Up to 88 percent of the mice in the study remained tumor-free, and the team are now turning their attention to human cancers.